A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50)
Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.
Benign and malignant tumors of the HYPOTHALAMUS. Pilocytic astrocytomas and hamartomas are relatively frequent histologic types. Neoplasms of the hypothalamus frequently originate from adjacent structures, including the OPTIC CHIASM, optic nerve (see OPTIC NERVE NEOPLASMS), and pituitary gland (see PITUITARY NEOPLASMS). Relatively frequent clinical manifestations include visual loss, developmental delay, macrocephaly, and precocious puberty. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2051)
A bony prominence situated on the upper surface of the body of the sphenoid bone. It houses the PITUITARY GLAND.
Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN). This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions.
A tumor composed of cells resembling those of the hair matrix, which undergo 'mummification' and may calcify. It is a relatively uncommon tumor, which may occur at any age from infancy. The majority of patients are under 20, and females are affected more than males. The lesion is usually a solitary deep dermal or subcutaneous tumor 3-30 mm in diameter, situated in the head, neck, or upper extremity. (From Rook et al., Textbook of Dermatology, 4th ed, p2401)
Ocular disorders attendant upon non-ocular disease or injury.
A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.
Neoplasms located in the brain ventricles, including the two lateral, the third, and the fourth ventricle. Ventricular tumors may be primary (e.g., CHOROID PLEXUS NEOPLASMS and GLIOMA, SUBEPENDYMAL), metastasize from distant organs, or occur as extensions of locally invasive tumors from adjacent brain structures.
Congenital or acquired cysts of the brain, spinal cord, or meninges which may remain stable in size or undergo progressive enlargement.
A narrow cleft inferior to the CORPUS CALLOSUM, within the DIENCEPHALON, between the paired thalami. Its floor is formed by the HYPOTHALAMUS, its anterior wall by the lamina terminalis, and its roof by EPENDYMA. It communicates with the FOURTH VENTRICLE by the CEREBRAL AQUEDUCT, and with the LATERAL VENTRICLES by the interventricular foramina.
A mixed radiolucent-radiopaque lesion of the jaws with features of both a cyst and a solid neoplasm. It is characterized microscopically by an epithelial lining showing a palisaded layer of columnar basal cells, presence of ghost cell keratinization, dentinoid, and calcification. (Stedman, 25th ed)
Surgery performed on the nervous system or its parts.
Neoplasms of the base of the skull specifically, differentiated from neoplasms of unspecified sites or bones of the skull (SKULL NEOPLASMS).
A genetic or acquired polyuric disorder caused by a deficiency of VASOPRESSINS secreted by the NEUROHYPOPHYSIS. Clinical signs include the excretion of large volumes of dilute URINE; HYPERNATREMIA; THIRST; and polydipsia. Etiologies include HEAD TRAUMA; surgeries and diseases involving the HYPOTHALAMUS and the PITUITARY GLAND. This disorder may also be caused by mutations of genes such as ARVP encoding vasopressin and its corresponding neurophysin (NEUROPHYSINS).
An irregular unpaired bone situated at the SKULL BASE and wedged between the frontal, temporal, and occipital bones (FRONTAL BONE; TEMPORAL BONE; OCCIPITAL BONE). Sphenoid bone consists of a median body and three pairs of processes resembling a bat with spread wings. The body is hollowed out in its inferior to form two large cavities (SPHENOID SINUS).
Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES.
A demyelinating condition affecting the PONS and characterized clinically by an acute progressive QUADRIPLEGIA; DYSARTHRIA; DYSPHAGIA; and alterations of consciousness. Pathologic features include prominent demyelination in the central PONS with sparing of axons and neurons. This condition is usually associated with systemic disorders such as HYPONATREMIA; chronic ALCOHOLISM; LIVER FAILURE; severe BURNS; malignant NEOPLASMS; hemorrhagic PANCREATITIS; HEMODIALYSIS; and SEPSIS. The rapid medical correction of hyponatremia has been cited as a cause of this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1125-6)
Cancers or tumors of the MAXILLA or MANDIBLE unspecified. For neoplasms of the maxilla, MAXILLARY NEOPLASMS is available and of the mandible, MANDIBULAR NEOPLASMS is available.
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
The X-shaped structure formed by the meeting of the two optic nerves. At the optic chiasm the fibers from the medial part of each retina cross to project to the other side of the brain while the lateral retinal fibers continue on the same side. As a result each half of the brain receives information about the contralateral visual field from both eyes.

Cyclic compression of the intracranial optic nerve: patterns of visual failure and recovery. (1/203)

A patient with a cystic craniopharyngioma below the right optic nerve had several recurrences requiring surgery. Finally the cyst was connected with a subcutaneous reservoir by means of a fine catheter. Symptoms of optic nerve compression recurred more than 50 times during the following year, and were relieved within seconds upon drainage of the reservoir. In each cycle, a drop in visual acuity preceded a measurable change in the visual field. The pattern of field changes was an increasingly severe, uniform depression. Optic nerve ischaemia induced by compression was probably the most important factor causing visual failure in this case.  (+info)

Recovery from anterograde and retrograde amnesia after percutaneous drainage of a cystic craniopharyngioma. (2/203)

A case is reported of a cystic craniopharyngioma involving the floor and walls of the third ventricle. Pronounced anterograde and retrograde amnesia were documented preoperatively by formal testing. Rapid improvement in both new learning capacity and remote memory occurred after percutaneous twist drill drainage of the cystic portion of the tumour. The relevance of these observations to the amnesic syndrome and its neuropathological basis is discussed.  (+info)

CT-guided stereotactic biopsy of deep brain lesions: report of 310 cases. (3/203)

OBJECTIVE: To evaluate the accuracy of CT-guided stereotactic biopsy in making correct pathological diagnosis and choosing corresponding management of brain tumors. METHODS: From 1991 to 1995, CT-guided stereotactic biopsy was performed in 310 patients with intracerebral lesions which were deep-seated or located in certain main functional areas. The patients were 198 men and 112 women. Their ages ranged from 4.5 to 70 years (average: 39.3 years). The lesions were located in the deep cerebrum (74 patients), the sellar area (62), the basal ganglion (51), the posterior part of the third ventricle (38), other intraventricleular area (21), the cerebellum (17) and the brain stem (9), and intracranial multiple lesions were found in 38 patients. RESULTS: Brain tumors were diagnosed pathologically in 266 patients (85.8%); inflammatory process in 25 (8.1%), other lesions in 8 (2.6%) and uncertain cases were 11 (3.6%). The overall positive rate of biopsy was 96.4% and the positive rate for brain tumor was 85.8%. Intracranial hematomas after biopsy were found in 5 patients (1.6%). There were no deaths induced by the biopsy or other serious complications. CONCLUSIONS: The results suggest that CT-guided stereotactic biopsy is a reliable method for histopathological diagnosis of brain tumors and it is also of great help in selecting appropriate management.  (+info)

Suprasellar arachnoid cyst presenting with precocious puberty : report of two cases. (4/203)

Suprasellar arachnoid cysts (SSAC) are uncommon intracranial lesions. Two patients of SSAC presenting with precocious puberty are described. In both the cases partial excision of the cyst wall, through a pterional craniotomy, establishing communication with the basal subarachnoid spaces was carried out. The endocrinological symptoms regressed after surgery. The clinical presentations of SSAC and the treatment options available are reviewed.  (+info)

Metastatic craniopharyngioma. (5/203)

We report a unique case of metastatic craniopharyngioma. Initially, the patient had a right frontal craniotomy for resection of a suprasellar mass, which was determined to be an adamantinomatous craniopharyngioma. Seven years later, an MR study of the brain showed two peripheral enhancing lesions adjacent to the dura and contralateral to the craniotomy site. Pathologic examination again showed adamantinomatous craniopharyngioma. Although recurrence, both local and along surgical tracts due to implantation of craniopharyngioma tissue, has been reported, this case raises the possibility of meningeal seeding to remote sites.  (+info)

Atypical Rathke's cleft cyst associated with ossification. (6/203)

We report a case of symptomatic Rathke's cleft cyst with ossification. CT scans showed curvilinear calcification on the wall of the cyst. MR images revealed a cystic sellar lesion with a nodular solid mass extending to the floor of the third ventricle. This case shows that calcification of the suprasellar cyst does not always suggest craniopharyngioma. Rathke's cysts should be histologically differentiated from craniopharyngiomas because their treatments are different.  (+info)

Long-term magnetic resonance imaging follow-up of asymptomatic sellar tumors. -- their natural history and surgical indications. (7/203)

Serial magnetic resonance (MR) images and clinical symptoms were analyzed in 23 patients with sellar lesions, who were followed up without initial therapy for mass reduction to evaluate their natural history and surgical indication for these lesions. The patients were aged 17 to 78 years (mean 47.3 years) and the follow-up period was 1.5 to 11.6 years (mean 5.1 years). Lesions were divided into two types based on the MR imaging findings, regardless of their histological types. Type C was cystic with or without enhancement of the smooth and thin wall. Type S had enhanced solid components. Ten patients had Type C tumors. Three patients presented with sudden onset of headache. The tumor size spontaneously decreased with intensity change, indicating pituitary apoplexy as the trigger of the onset and intensity change. Four patients presented with the visual disturbance which improved with the reduction of tumor size, but three patients deteriorated and required surgery. The operation revealed Rathke's cleft cyst. The remaining three patients were found incidentally and have been asymptomatic without MR imaging changes. Thirteen patients had Type S tumors. Six patients of nine with 14 mm or larger tumors developed symptomatic tumor enlargement over the follow-up period of 1.2 to 8.6 years (mean 4.9 years) and required treatment. The remainder showed no change. Type C tumors frequently shrink or even disappear spontaneously. We can justify conservative follow-up of Type C tumors in patients with no or only transient symptoms. Type S tumors, larger than 14 mm in size, need closer observation or treatment because they often enlarge and become symptomatic.  (+info)

Tension pneumocephalus after neurosurgery in the supine position. (8/203)

Tension pneumocephalus has been reported most frequently after posterior fossa surgery performed in the sitting position. We present a paediatric patient who developed tension pneumocephalus in the postoperative period after decompression of a craniopharyngioma performed with the patient in the supine position.  (+info)

Craniopharyngiomas are classified into three main types based on their location and characteristics:

1. Suprasellar craniopharyngioma: This type of tumor grows near the pineal gland and can affect the hypothalamus.
2. Intrasellar craniopharyngioma: This type of tumor grows within the sella turcica, a bony cavity in the sphenoid sinus that contains the pituitary gland.
3. Posterior craniopharyngioma: This type of tumor grows near the optic nerve and hypothalamus.

Craniopharyngiomas are usually treated with surgery, and in some cases, radiation therapy may be recommended to remove any remaining cancer cells. The prognosis for this condition is generally good, but it can vary depending on the size and location of the tumor, as well as the age of the patient.

In addition to surgery and radiation therapy, hormone replacement therapy may also be necessary to treat hormonal imbalances caused by the tumor. It is important for patients with craniopharyngioma to receive ongoing medical care to monitor their condition and address any complications that may arise.

Some common types of pituitary neoplasms include:

1. Adenomas: These are benign tumors that grow slowly and often do not cause any symptoms in the early stages.
2. Craniopharyngiomas: These are rare, slow-growing tumors that can be benign or malignant. They can affect the pituitary gland, the hypothalamus, and other areas of the brain.
3. Pituitary carcinomas: These are malignant tumors that grow quickly and can spread to other parts of the body.
4. Pituitary metastases: These are tumors that have spread to the pituitary gland from another part of the body, such as breast cancer or lung cancer.

Symptoms of pituitary neoplasms can vary depending on the size and location of the tumor, but they may include:

* Headaches
* Vision changes, such as blurred vision or loss of peripheral vision
* Hormonal imbalances, which can lead to a variety of symptoms including fatigue, weight gain or loss, and irregular menstrual cycles
* Cognitive changes, such as memory loss or difficulty with concentration
* Pressure on the brain, which can cause nausea, vomiting, and weakness or numbness in the limbs

Diagnosis of pituitary neoplasms typically involves a combination of imaging tests, such as MRI or CT scans, and hormone testing to determine the level of hormones in the blood. Treatment options can vary depending on the type and size of the tumor, but they may include:

* Watchful waiting: Small, benign tumors may not require immediate treatment and can be monitored with regular imaging tests.
* Medications: Hormone replacement therapy or medications to control hormone levels may be used to manage symptoms.
* Surgery: Tumors can be removed through a transsphenoidal surgery, which involves removing the tumor through the nasal cavity and sphenoid sinus.
* Radiation therapy: May be used to treat residual tumor tissue after surgery or in cases where the tumor cannot be completely removed with surgery.

Overall, pituitary neoplasms are rare and can have a significant impact on the body if left untreated. If you suspect you may have a pituitary neoplasm, it is important to seek medical attention for proper diagnosis and treatment.

Some common types of hypothalamic neoplasms include:

1. Hypothalamic hamartoma: A benign tumor that usually develops in children and is characterized by abnormal growth of brain tissue.
2. Pineal parenchymal tumors: Tumors that originate in the pineal gland, a small endocrine gland located in the hypothalamus. These tumors can be benign or malignant and can cause symptoms such as headaches, vision problems, and hormonal imbalances.
3. Hypothalamic astrocytomas: Malignant tumors that originate in the brain tissue of the hypothalamus and can spread to other parts of the brain.
4. Craniopharyngiomas: Benign tumors that develop near the pituitary gland, a small endocrine gland located at the base of the brain that regulates various bodily functions. These tumors can cause symptoms such as headaches, vision problems, and hormonal imbalances.

The symptoms of hypothalamic neoplasms can vary depending on their size, location, and type, but may include:

1. Headaches
2. Vision problems
3. Hormonal imbalances
4. Seizures
5. Weight gain or loss
6. Fatigue
7. Changes in mood or behavior
8. Cognitive impairment
9. Endocrine dysfunction

The diagnosis of hypothalamic neoplasms is based on a combination of clinical evaluation, imaging studies such as MRI or CT scans, and tissue sampling through biopsy or surgery. Treatment options for these tumors depend on the type, size, and location of the tumor, and may include:

1. Observation: Small, benign tumors may not require immediate treatment and can be monitored with regular check-ups.
2. Surgery: To remove the tumor, either through a traditional open procedure or minimally invasive techniques.
3. Radiation therapy: To destroy any remaining tumor cells after surgery.
4. Chemotherapy: To shrink the tumor before surgery or to treat recurrences.
5. Hormone replacement therapy: To replace hormones that are deficient due to hypopituitarism.

The prognosis for hypothalamic neoplasms depends on the type and location of the tumor, as well as the patient's overall health. In general, benign tumors have a good prognosis, while malignant tumors are more challenging to treat and may have a poorer outcome.

The symptoms of hypopituitarism can vary depending on the specific hormone deficiency and can include:

1. Growth hormone deficiency: Short stature, delayed puberty, and decreased muscle mass.
2. Adrenocorticotropic hormone (ACTH) deficiency: Weakness, fatigue, weight loss, and low blood pressure.
3. Thyroid-stimulating hormone (TSH) deficiency: Hypothyroidism, decreased metabolism, dry skin, and constipation.
4. Prolactin deficiency: Lack of milk production in lactating women, erectile dysfunction, and infertility.
5. Vasopressin (ADH) deficiency: Increased thirst and urination.
6. Oxytocin deficiency: Difficulty breastfeeding, low milk supply, and uterine atony.

Hypopituitarism can be caused by a variety of factors such as:

1. Traumatic brain injury or surgery
2. Tumors, cysts, or inflammation in the pituitary gland or hypothalamus
3. Radiation therapy
4. Infections such as meningitis or encephalitis
5. Autoimmune disorders such as hypophyseal lymphocytic infiltration
6. Genetic mutations

Diagnosis of hypopituitarism involves a series of tests to assess the levels of hormones in the blood and urine, as well as imaging studies such as MRI or CT scans to evaluate the pituitary gland. Treatment depends on the specific hormone deficiency and can include hormone replacement therapy, surgery, or radiation therapy. In some cases, hypopituitarism may be a temporary condition that resolves once the underlying cause is treated. However, in other cases, it may be a lifelong condition requiring ongoing management.

In conclusion, hypopituitarism is a rare but potentially debilitating disorder that can affect various aspects of human physiology. It is important to be aware of the signs and symptoms of hypopituitarism and seek medical attention if they persist or worsen over time. With proper diagnosis and treatment, individuals with hypopituitarism can lead relatively normal lives.

Pilomatricoma is thought to arise from the abnormal growth and development of matrical cells, which are responsible for producing the protein components of the hair follicle. The tumor typically does not grow or change over time, and is usually asymptomatic unless it becomes infected or irritated.

Pilomatricoma is relatively rare, accounting for less than 1% of all skin tumors. It is most commonly seen in adults between the ages of 20 and 50, although it can occur at any age. The exact cause of pilomatricoma is not known, but it may be associated with genetic mutations or environmental factors that affect the development of hair follicles.

There are several methods for diagnosing pilomatricoma, including:

* Clinical examination: A healthcare provider will typically examine the tumor and surrounding skin to determine its size, shape, color, and texture.
* Biopsy: A small sample of tissue from the tumor may be removed and examined under a microscope to confirm the diagnosis.
* Imaging studies: CT or MRI scans may be used to evaluate the size and extent of the tumor, as well as any potential involvement of surrounding structures.

Treatment for pilomatricoma usually involves surgical excision of the tumor, although in some cases, observation or laser therapy may be appropriate. The prognosis for pilomatricoma is generally excellent, as it is a benign condition that does not spread to other parts of the body (metastasize). However, if the tumor becomes infected or irritated, complications such as abscesses or scarring may occur.

In summary, pilomatrixoma is a rare, benign skin tumor that arises from matrical cells in the hair follicle. It typically presents as a slow-growing, flesh-colored or pink nodule on the face, neck, or scalp. Diagnosis is based on clinical examination and imaging studies, and treatment involves surgical excision or observation. The prognosis is generally excellent, but complications can occur if the tumor becomes infected or irritated.

Some common examples of eye manifestations include:

1. Redness or inflammation of the conjunctiva (the thin membrane that covers the white part of the eye): This can be a sign of an infection, allergy, or other condition.
2. Discharge or crusting around the eyes: This can be a sign of an infection or allergies.
3. Swelling of the eyelids or eye socket: This can be a sign of an infection, injury, or other condition.
4. Bulging of one or both eyes (proptosis): This can be a sign of a tumor or other condition that is putting pressure on the eye socket.
5. Abnormal alignment of the eyes (strabismus): This can be a sign of a neurological disorder or other condition.
6. Blurring or distortion of vision: This can be a sign of a variety of conditions, including refractive errors, cataracts, glaucoma, or retinal detachment.
7. Abnormal pupillary reaction to light (photophobia): This can be a sign of a neurological disorder or other condition.
8. Eye twitching or spasms: This can be a sign of a neurological disorder or other condition.
9. Blind spots in the field of vision: This can be a sign of a retinal detachment or other condition.
10. Abnormal color vision (color blindness): This can be a sign of a genetic disorder or other condition.

Healthcare professionals may use a variety of tests and procedures to evaluate eye manifestations, including visual acuity tests, refraction tests, retinoscopy, and imaging studies such as ultrasound or MRI. Treatment of eye manifestations depends on the underlying cause and can range from glasses or contact lenses for refractive errors to surgery for cataracts or retinal detachment. In some cases, treatment of the underlying condition can help resolve the eye manifestations.

There are two main types of DI: central diabetes insipidus (CDI) and nephrogenic diabetes insipidus (NDI). CDI is caused by a defect in the hypothalamus or pituitary gland, which can lead to a lack of vasopressin. NDI is caused by a problem with the kidneys, which can prevent them from responding properly to vasopressin.

Symptoms of DI include excessive thirst and urination, fatigue, headaches, and dehydration. Treatment for DI typically involves replacing vasopressin through injections or oral medications, as well as addressing any underlying causes. In some cases, DI can be managed with desmopressin, a synthetic version of vasopressin.

Overall, diabetes insipidus is a rare and complex condition that requires careful management to prevent complications such as dehydration and electrolyte imbalances.

The symptoms of cerebral ventricle neoplasms depend on their size, location, and growth rate. They may include headaches, seizures, weakness or numbness in the arms or legs, and changes in personality or cognitive function. As the tumor grows, it can press on surrounding brain tissue and disrupt normal brain function.

Diagnosis of cerebral ventricle neoplasms typically involves a combination of imaging studies such as CT or MRI scans, and tissue sampling through a biopsy procedure. Treatment options for cerebral ventricle neoplasms depend on the type and location of the tumor, as well as the patient's overall health status. Surgery, radiation therapy, and chemotherapy may be used alone or in combination to treat these tumors.

Examples of types of cerebral ventricle neoplasms include:

1. Choroid plexus papilloma: A benign tumor that arises from the choroid plexus, a layer of tissue that lines the ventricles and produces cerebrospinal fluid.
2. Choroid plexus carcinoma: A malignant tumor that arises from the choroid plexus.
3. Ventricular ependymoma: A tumor that arises from the ependyma, a layer of tissue that lines the ventricles and helps to move cerebrospinal fluid through the brain.
4. Subependymal giant cell astrocytoma (SEGA): A rare benign tumor that arises from the subependymal layer of tissue, which is located beneath the ependyma.

Overall, cerebral ventricle neoplasms are a complex and diverse group of brain tumors that can have significant impacts on the brain and nervous system. Treatment options vary depending on the specific type of tumor and the individual patient's needs.

Central nervous system cysts are typically diagnosed through imaging tests such as CT or MRI scans. Treatment options for central nervous system cysts vary depending on the size, location, and symptoms of the cyst, but may include observation, surgery, or endoscopic procedures to drain or remove the cyst.

Some common types of central nervous system cysts include:

1. Arachnoid cysts: These are flattened sacs that form between the layers of tissue that cover the brain and spinal cord (meninges).
2. Ventricular cysts: These are cysts that form within the ventricles, which are fluid-filled spaces within the brain.
3. Cerebral cysts: These are cysts that form within the tissue of the brain.
4. Spinal cysts: These are cysts that form within the spinal cord or along the spine.
5. Neurocysticercosis: This is a parasitic infection caused by the larvae of the pork tapeworm, which can form cysts within the brain and spinal cord.

While central nervous system cysts are generally not cancerous, they can still cause significant health problems if left untreated. It is important to seek medical attention if symptoms persist or worsen over time, as early diagnosis and treatment can help prevent complications and improve outcomes.

Note: Odontogenic cysts are non-cancerous growths that originate in the tissues of the teeth and jaw. They can be benign or malignant, and their exact nature can only be determined through a biopsy.

Types of Skull Base Neoplasms:

1. Meningioma: A benign tumor that arises from the meninges, the protective membranes covering the brain and spinal cord.
2. Acoustic neuroma (vestibular schwannoma): A benign tumor that grows on the nerve that connects the inner ear to the brain.
3. Pineal parenchymal tumors: Tumors that occur in the pineal gland, a small endocrine gland located in the brain.
4. Craniopharyngiomas: Benign tumors that arise from the cells of the pituitary gland and the hypothalamus.
5. Chordomas: Malignant tumors that arise from the cells of the notochord, a structure that gives rise to the spinal cord.
6. Chondrosarcomas: Malignant tumors that arise from cartilage cells.
7. Osteosarcomas: Malignant tumors that arise from bone cells.
8. Melanotic neuroectodermal tumors: Rare tumors that are usually benign but can sometimes be malignant.

Causes and Symptoms of Skull Base Neoplasms:

The exact cause of skull base neoplasms is not always known, but they can be associated with genetic mutations or exposure to certain environmental factors. Some of the symptoms of skull base neoplasms include:

* Headaches
* Vision problems
* Hearing loss
* Balance and coordination difficulties
* Seizures
* Weakness or numbness in the face or limbs
* Endocrine dysfunction (in case of pituitary tumors)

Diagnosis of Skull Base Neoplasms:

The diagnosis of skull base neoplasms usually involves a combination of imaging studies such as CT or MRI scans, and tissue sampling through biopsy or surgery. The specific diagnostic tests will depend on the location and symptoms of the tumor.

Treatment of Skull Base Neoplasms:

The treatment of skull base neoplasms depends on the type, size, location, and aggressiveness of the tumor, as well as the patient's overall health. Some of the treatment options for skull base neoplasms include:

* Surgery: The primary treatment for most skull base neoplasms is surgical resection. The goal of surgery is to remove as much of the tumor as possible while preserving as much normal tissue as possible.
* Radiation therapy: Radiation therapy may be used before or after surgery to shrink the tumor and kill any remaining cancer cells.
* Chemotherapy: Chemotherapy may be used in combination with radiation therapy to treat skull base neoplasms that are aggressive or have spread to other parts of the body.
* Endoscopic surgery: Endoscopic surgery is a minimally invasive procedure that uses a thin, lighted tube with a camera on the end (endoscope) to remove the tumor through the nasal cavity or sinuses.
* Stereotactic radiosurgery: Stereotactic radiosurgery is a non-invasive procedure that uses highly focused radiation beams to destroy the tumor. It is typically used for small, well-defined tumors that are located in sensitive areas of the skull base.

Prognosis for Skull Base Neoplasms:

The prognosis for skull base neoplasms depends on the type and location of the tumor, as well as the patient's overall health. In general, the prognosis for patients with skull base neoplasms is good if the tumor is small, located in a accessible area, and has not spread to other parts of the body. However, the prognosis may be poorer for patients with larger or more aggressive tumors, or those that have spread to other parts of the body.

It's important to note that each patient is unique and the prognosis can vary depending on individual circumstances. It is best to consult a medical professional for specific information about the prognosis for your condition.

ADH is produced by the hypothalamus and helps regulate the amount of water in the body by controlling the amount of urine produced by the kidneys. In people with NDI, the damaged hypothalamus produces either too much or too little ADH, leading to an imbalance in fluid levels. This can cause excessive thirst and urination, as well as other symptoms such as headaches, nausea, and fatigue.

Neurogenic diabetes insipidus is different from diabetes mellitus, which is a condition that affects blood sugar levels. NDI does not affect blood sugar levels, but it can still cause significant problems if left untreated. Treatment for NDI typically involves medication to regulate fluid levels and correct any hormone imbalances. In severe cases, surgery may be necessary to remove a tumor or repair damage to the hypothalamus.

The endocrine system is a network of glands and hormones that regulate various bodily functions, such as growth, development, metabolism, and reproductive processes. Endocrine system diseases refer to disorders or abnormalities that affect one or more of the endocrine glands or the hormones they produce.

Types of Endocrine System Diseases:

1. Diabetes Mellitus (DM): A group of metabolic disorders characterized by high blood sugar levels due to insulin deficiency or insulin resistance.
2. Hypothyroidism: A condition where the thyroid gland does not produce enough thyroid hormones, leading to symptoms such as fatigue, weight gain, and cold intolerance.
3. Hyperthyroidism: A condition where the thyroid gland produces too much thyroid hormone, leading to symptoms such as anxiety, weight loss, and heart palpitations.
4. Cushing's Syndrome: A rare disorder caused by excessive levels of cortisol hormone in the body, leading to symptoms such as weight gain, high blood pressure, and mood changes.
5. Addison's Disease: A rare disorder caused by a deficiency of cortisol and aldosterone hormones in the body, leading to symptoms such as fatigue, weight loss, and dehydration.
6. Pituitary Gland Disorders: Tumors or cysts in the pituitary gland can affect the production of hormones that regulate other endocrine glands.
7. Adrenal Insufficiency: A condition where the adrenal glands do not produce enough cortisol and aldosterone hormones, leading to symptoms such as fatigue, weight loss, and dehydration.
8. Polycystic Ovary Syndrome (PCOS): A hormonal disorder that affects women of reproductive age, characterized by irregular menstrual cycles, cysts on the ovaries, and insulin resistance.
9. Graves' Disease: An autoimmune disorder that causes hyperthyroidism (an overactive thyroid gland), leading to symptoms such as rapid weight loss, nervousness, and heart palpitations.
10. Hashimoto's Thyroiditis: An autoimmune disorder that causes hypothyroidism (an underactive thyroid gland), leading to symptoms such as fatigue, weight gain, and depression.

These are just a few examples of endocrine disorders, and there are many more that can affect different parts of the endocrine system. It's important to be aware of the signs and symptoms of these disorders so that you can seek medical attention if you experience any unusual changes in your body.

There are several types of jaw neoplasms, including:

1. Ameloblastoma: A benign tumor that arises from the odontogenic epithel (the cells that form teeth).
2. Odontogenic carcinoma: A malignant tumor that arises from the odontogenic epithel.
3. Squamous cell carcinoma: A malignant tumor that arises from the squamous epithel (the cells that line the mouth and throat).
4. Osteosarcoma: A malignant bone tumor that can occur in the jawbone.
5. Ewing's sarcoma: A rare, malignant bone tumor that can occur in the jawbone.

Jaw neoplasms can cause a variety of symptoms, including pain, swelling, and difficulty opening the mouth. Treatment depends on the type and location of the tumor, and may involve surgery, radiation therapy, or chemotherapy.

Prognosis for jaw neoplasms varies depending on the type and stage of the tumor. Early detection and treatment can improve outcomes for patients with benign tumors, while malignant tumors can be more challenging to treat and may have a lower survival rate.

There are several risk factors for developing jaw neoplasms, including genetic predisposition, exposure to radiation, and certain medical conditions such as dental trauma or infections. Regular dental check-ups and early detection can help to identify tumors at an early stage and improve treatment outcomes.

In summary, jaw neoplasms are abnormal growths that can occur in the jawbone and can be benign or malignant. Treatment options vary depending on the type and location of the tumor, and early detection is key to improving outcomes for patients with these conditions.

Brain neoplasms can arise from various types of cells in the brain, including glial cells (such as astrocytes and oligodendrocytes), neurons, and vascular tissues. The symptoms of brain neoplasms vary depending on their size, location, and type, but may include headaches, seizures, weakness or numbness in the limbs, and changes in personality or cognitive function.

There are several different types of brain neoplasms, including:

1. Meningiomas: These are benign tumors that arise from the meninges, the thin layers of tissue that cover the brain and spinal cord.
2. Gliomas: These are malignant tumors that arise from glial cells in the brain. The most common type of glioma is a glioblastoma, which is aggressive and hard to treat.
3. Pineal parenchymal tumors: These are rare tumors that arise in the pineal gland, a small endocrine gland in the brain.
4. Craniopharyngiomas: These are benign tumors that arise from the epithelial cells of the pituitary gland and the hypothalamus.
5. Medulloblastomas: These are malignant tumors that arise in the cerebellum, specifically in the medulla oblongata. They are most common in children.
6. Acoustic neurinomas: These are benign tumors that arise on the nerve that connects the inner ear to the brain.
7. Oligodendrogliomas: These are malignant tumors that arise from oligodendrocytes, the cells that produce the fatty substance called myelin that insulates nerve fibers.
8. Lymphomas: These are cancers of the immune system that can arise in the brain and spinal cord. The most common type of lymphoma in the CNS is primary central nervous system (CNS) lymphoma, which is usually a type of B-cell non-Hodgkin lymphoma.
9. Metastatic tumors: These are tumors that have spread to the brain from another part of the body. The most common types of metastatic tumors in the CNS are breast cancer, lung cancer, and melanoma.

These are just a few examples of the many types of brain and spinal cord tumors that can occur. Each type of tumor has its own unique characteristics, such as its location, size, growth rate, and biological behavior. These factors can help doctors determine the best course of treatment for each patient.

"Craniopharyngioma". The Lecturio Medical Concept Library. Retrieved 10 July 2021. Müller HL (June 2014). "Craniopharyngioma". ... "Craniopharyngioma - Childhood: Diagnosis , Cancer.Net". Cancer.Net. 2012-06-25. Retrieved 2017-12-09. "Craniopharyngioma". UCLA ... "Use of Surgical Navigation for Craniopharyngioma Removal". January 2013. Wisoff JH (February 2008). "Craniopharyngioma". ... A craniopharyngioma is a rare type of brain tumor derived from pituitary gland embryonic tissue that occurs most commonly in ...
"Craniopharyngioma". NORD (National Organization for Rare Disorders). Bejjani, Ghassan K.; Cockerham, Kimberly P.; Kennerdell, ... Compression of the optic chiasm is associated with pituitary adenoma, Craniopharyngioma, Meningioma etc. A lesion involving ... Extrinsic or compressive lesions are caused by pituitary craniopharyngioma, tumours of optic thalamus. Other causes include ... "Pearls & Oy-sters: Optic tract syndrome" (PDF). {{cite journal}}: Cite journal requires ,journal= (help) "Craniopharyngioma ...
Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst". American Journal of Clinical Pathology. 120 (5): 732-736. ...
Erdheim tumor: a synonym for craniopharyngioma. He used the term "nanosomia pituitaria" to describe pituitary dwarfism. Uber ...
They are found in: Craniopharyngioma (Rathke pouch) Odontoma Ameloblastic fibroma Calcifying odontogenic cyst (Gorlin cyst) ... "The Spectrum of Malignancy in Craniopharyngioma". The American Journal of Surgical Pathology. 31 (7): 1020-8. doi:10.1097/PAS. ...
Scopis Surgical Navigation (23 November 2012). Scopis Augmented Reality: Path guidance to craniopharyngioma. YouTube. Retrieved ...
ISBN 0-7216-3256-4. Lustig, Robert H (November 2011). "Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and ...
ISBN 978-0-7216-3256-8. Lustig RH (2011). "Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment ...
Other diagnoses to consider include craniopharyngioma, migraine and meningioma. Treatment of Tolosa-Hunt syndrome includes ...
Melatonin deficiency and disrupted circadian rhythms in pediatric survivors of craniopharyngioma. Neurology 2009; 73:323-25. ...
Called craniopharyngioma, the tumor could have caused blindness if left untreated. The surgery was successful. In November 2010 ...
Rohrer TR, Fahlbusch R, Buchfelder M, Dörr HG (2006). "Craniopharyngioma in a female adolescent presenting with symptoms of ...
... especially craniopharyngioma tumors. Sometimes it is used to treat Cushing's syndrome due to pituitary adenoma or Simmond's ...
Pathological causes of weight gain include Cushing's syndrome, hypothyroidism, insulinoma, and craniopharyngioma. Genetic ...
Scopis Augmented Reality: Path guidance to craniopharyngioma on YouTube Loy Rodas, Nicolas; Padoy, Nicolas (2014). "3D Global ...
Craniopharyngioma is a neoplasm which can arise from the epithelium within the cleft. It is named for Martin Rathke. Rathke's ...
... a 15-year-old female with well-documented hypopituitarism secondary to a craniopharyngioma; a 53-year-old female with carcinoma ...
The embryonic remnants of Rathke's pouch may undergo neoplastic change called a craniopharyngioma. These tumors may develop at ...
In April 1997, Gramm was diagnosed with a type of brain tumor called a craniopharyngioma. Although the tumor was benign, the ...
... a craniopharyngioma, a chordoma, or a chordoid meningioma. In particular, meningiomas are known to produce musical auditory ...
Craniopharyngioma, and Calcifying Odontogenic Cyst". American Journal of Clinical Pathology. 120 (5): 732-6. doi:10.1309/ ...
They may be mistaken for the much more common pituitary adenoma, as well as craniopharyngioma and meningioma. Symptoms from the ...
Principal causes include: Pituitary adenoma or craniopharyngioma: Tumors in the pituitary gland can suppress production of ... craniopharyngioma) which can take up space and interfere with the secretion of pituitary hormones such as ACTH, therefore ...
CNS disorders such as childhood brain tumors (e.g. craniopharyngioma, prolactinoma, germinoma, glioma) can disrupt the ...
... to certain cases of papillary craniopharyngioma development. Other mutations which have been found are R461I, I462S, G463E, ...
... craniopharyngioma, some types of glioma); whilst calcification in such normal structures as the pineal body, the choroid ...
... and a diagnosis of craniopharyngioma. Apart from cardiovascular disease, this study also showed an increased risk of death from ...
... documented clinical application of Leksell's stereotactic system was a case of a craniopharyngioma cyst that was punctured and ...
Augmented Reality: Path guidance to craniopharyngioma on YouTube Manhas S, Vizet J, Deby S, Vanel JC, Boito P, Verdier M, De ...
... typically a craniopharyngioma. Quadrantanopia (quadrantanopsia or quadrantic hemianopsia) is decreased vision or blindness in ...
A craniopharyngioma is a noncancerous (benign) tumor that develops at the base of the brain near the pituitary gland. ... A craniopharyngioma is a noncancerous (benign) tumor that develops at the base of the brain near the pituitary gland. ... Usually, surgery has been the main treatment for craniopharyngioma. However, radiation treatment instead of surgery or along ... There may be long-term hormone, vision, and nervous system problems after craniopharyngioma is treated. ...
The monoclonal antibody NCL-CK13 was studied in specimens of craniopharyngioma, ameloblastoma and calcifying odontogenic cyst ...
Data of patients with CDI who underwent EES for craniopharyngioma between February 2009 and June 2021 were retrospectively ... Central diabetes insipidus (CDI) is the most common complication of endoscopic endonasal surgery (EES) for craniopharyngioma. ... and the Hong et al HI pattern might be predictors of the spontaneous resolution of CDI following EES for craniopharyngioma. ... of the Spontaneous Resolution of Central Diabetes Insipidus Following Endoscopic Endonasal Surgery for Craniopharyngioma. ...
Craniopharyngioma * Melanotic Neuroectodermal Tumor of Infancy * Surgery for Craniopharyngiomas * Craniopharyngioma Pathology * ...
Craniopharyngioma: A type of noncancerous tumor found near the pituitary gland, craniopharyngiomas usually occur in children ...
The Providence Brain Tumor Center, part of the Providence Brain and Spine Institute, combines world-class expertise and technology with compassionate care.
Craniopharyngioma. Posted in Computed Tomography, Magnetic Resonance, Neuroradiology Intracranial metastases from prostate ... Craniopharyngioma. Posted on July 7, 2022. by Ivan Wolansky ...
Get free answers on any health question about the test FSH from top U.S. doctors. Or, video or text chat with a U.S. doctor 24/7 on demand for advice, prescriptions and more for an affordable fee.
Craniopharyngioma (C75.2). 9351/1. Craniopharyngioma, adamantinomatous (C75.2). 9352/1. Craniopharyngioma, papillary (C75.2). ...
... it is miraculous Kalkidan made it to Sacramento to receive treatment for her craniopharyngioma, Kalkidans form of... ... Craniopharyngioma is more common among children because it often exists at birth, Ciricillo said. "Things we see abroad tend to ... it is miraculous Kalkidan made it to Sacramento to receive treatment for her craniopharyngioma, Kalkidans form of cancer ...
At age 5, he was diagnosed with a Craniopharyngioma. Has there been studies on children of firefighters developing brain tumors ...
Tumors of the brain (e.g., meningioma, craniopharyngioma, gliomas). Tumors of the pituitary (e.g., microadenoma). ...
The CT scan revealed a brain tumor called Craniopharyngioma. The Dabon family is raising money for the Pediatric Brain Tumor ...
A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive ...
Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma. ...
Familial adenomatous polyposis associated craniopharyngioma secondary to both germline and somatic mutations in the APC gene. ...
The differential diagnosis includes other cysts (e.g. neurenteric cysts), hypothalamic hamartoma or a craniopharyngioma; the ...
... and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer ... Growth in children with craniopharyngioma following surgery. Clin Endocrinol (Oxf). 1998;49(6):733-738. ...
Craniopharyngioma is a rare brain tumor that forms in the central region of the brain, making it difficult to treat without ... Whats unique about craniopharyngioma is that its consistently located in the central part of the brain and intimately ... The clinical trial may set the new gold standard for pediatric craniopharyngioma treatment. The study was published today in ... Jude Childrens Research Hospital is reporting phase 2 clinical trial results treating the brain tumor craniopharyngioma with ...
... craniopharyngioma (6%), and other tumor types (13%). In 10% of patients, the pathological findings were inconclusive. According ...
craniopharyngioma lub meningioma). y podwzgórze lub przysadka. - zespół pustego siodła. - choroba ziarniniakowa. - złamania ...
Other brain tumors, such as astrocystoma, craniopharyngioma, and oligodendroglioma, are infrequent, while meningioma is ... craniopharyngioma, mesenchymoma, Hodgkins lymphoma, non-Hodgkins lymphoma, seminoma, paratesticular pseudotumor, schwannoma, ...
It presents images and case reports related to brain tumors (astrocytomas, craniopharyngioma, glioblastomas, medulloblastomas, ...
Child Craniopharyngioma. Child Craniopharyngiomas. Craniopharyngioma, Adamantinous. Craniopharyngioma, Adult. Craniopharyngioma ... Child Craniopharyngioma Child Craniopharyngiomas Craniopharyngiomas, Child Craniopharyngioma, Adamantinous - Narrower Concept ... Craniopharyngioma, Papillary Entry term(s). Craniopharyngiomas, Papillary Papillary Craniopharyngioma Papillary ... Craniopharyngioma, Adamantinous Entry term(s). Adamantinous Craniopharyngioma Adamantinous Craniopharyngiomas ...
BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous ...
Learn Pilocytic Astrocytoma - Nervous System Cancer (Neuro-oncology) - Pathology for Medicine faster and easier with Picmonics unforgettable videos, stories, and quizzes! Picmonic is research proven to increase your memory retention and test scores. Start learning today for free!
  • A craniopharyngioma is a noncancerous (benign) tumor that develops at the base of the brain near the pituitary gland. (medlineplus.gov)
  • This book aims to facilitate readers to understand the origin, growth pattern and relationship between tumor and adherent structure of craniopharyngioma, so as to improve the cure rate and safety of surgery. (ebooksz.net)
  • This classification method can better reflect the different origin and growth pattern of craniopharyngioma,the relationship between tumors and surrounding structure of the tumor growth pattern, and clinical significance in surgery. (ebooksz.net)
  • The CT scan revealed a brain tumor called Craniopharyngioma. (wbrc.com)
  • 8. Creative and Innovative Methods and Techniques for the Challenges in the Management of Adult Craniopharyngioma. (nih.gov)
  • 17. Clinical Situation, Therapy, and Follow-Up of Adult Craniopharyngioma. (nih.gov)
  • The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. (nih.gov)
  • 20. Craniopharyngioma with malignant transformation: Review of literature. (nih.gov)
  • Meningiomas(36.4%), craniopharyngioma(13.6%) and gliomas(9.1%) were the most common brain tumours encountered. (who.int)
  • some of these tumors (eg craniopharyngioma) are included among the most common central nervous system tumors in childhood. (nih.gov)
  • 5. Interventions for the Treatment of Craniopharyngioma-Related Hypothalamic Obesity: A Systematic Review. (nih.gov)
  • 11. Liraglutide 3mg as a weight-loss strategy after failed bariatric surgery in a patient with hypothalamic obesity following craniopharyngioma. (nih.gov)
  • 16. Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy. (nih.gov)
  • 3. Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up--recommendations in KRANIOPHARYNGEOM 2000. (nih.gov)
  • There are no known risk factors for childhood craniopharyngioma. (wustl.edu)
  • Signs of childhood craniopharyngioma include vision changes and slow growth. (wustl.edu)
  • 1. Childhood craniopharyngioma - current status and recent perspectives in diagnostics and treatment. (nih.gov)
  • 4. Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma. (nih.gov)
  • 7. Childhood craniopharyngioma: current controversies on management in diagnostics, treatment and follow-up. (nih.gov)
  • 9. Management of Childhood-onset Craniopharyngioma in Italy: A Multicenter, 7-Year Follow-up Study of 145 Patients. (nih.gov)
  • 15. Childhood-onset Craniopharyngioma. (nih.gov)
  • 18. Childhood craniopharyngioma. (nih.gov)
  • It's contributed by Neurosurgery Department of Nanfang Hospital, Southern Medical University, China, which focuses on the management of craniopharyngioma. (ebooksz.net)
  • Data of patients with CDI who underwent EES for craniopharyngioma between February 2009 and June 2021 were retrospectively reviewed. (bvsalud.org)
  • 14 patients ont été pris en charge par les ophtalmologistes. (who.int)
  • Usually, surgery has been the main treatment for craniopharyngioma. (medlineplus.gov)
  • IMSEAR at SEARO: Craniopharyngioma: treatment by conservative surgery and radiation therapy. (who.int)
  • Predictors of the Spontaneous Resolution of Central Diabetes Insipidus Following Endoscopic Endonasal Surgery for Craniopharyngioma. (bvsalud.org)
  • Central diabetes insipidus (CDI) is the most common complication of endoscopic endonasal surgery (EES) for craniopharyngioma . (bvsalud.org)
  • Craniopharyngioma or its surgery induces diabetes mellitus. (nel.edu)
  • The 70 clinical cases with different classification and treatment history are discussed as an important reference for surgical treatment of craniopharyngioma. (ebooksz.net)
  • But according to the health professionals involved, it is miraculous Kalkidan made it to Sacramento to receive treatment for her craniopharyngioma, Kalkidan's form of cancer discovered in the fall. (arizona.edu)
  • This book covers histoembryology of craniopharyngioma, together with anatomical morphology and abundant clinical data, systematically showing an innovative classification method, i.e. (ebooksz.net)
  • Craniopharyngioma is more common among children because it often exists at birth, Ciricillo said. (arizona.edu)
  • There may be long-term hormone, vision, and nervous system problems after craniopharyngioma is treated. (medlineplus.gov)
  • 19. Management of recurrent craniopharyngioma. (nih.gov)
  • The monoclonal antibody NCL-CK13 was studied in specimens of craniopharyngioma, ameloblastoma and calcifying odontogenic cyst neoplasms and the mandible and maxillae of normal human fetuses. (who.int)
  • It can be used as a diagnostic aid in such conditions as panhypopituitarism, pituitary dwarfism, chromophobe adenoma, postsurgical craniopharyngioma, hypophysectomy, pituitary trauma, acromegaly, gigantism and problems of growth and stature. (nih.gov)
  • Nowadays, craniopharyngioma must be considered a complex molecular disease, and a detailed explanation of the mechanisms underlying its aggressive biological and clinical behavior, despite some benign pathological features, would be the first step toward defining the best management of craniopharyngioma. (medscape.com)
  • 5. Targeted therapies in the medical management of craniopharyngioma. (nih.gov)
  • Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma:evidence for its odontogenic epithelial differentiation. (medscape.com)
  • 15. Adamantinomatous craniopharyngioma: moving toward targeted therapies. (nih.gov)
  • The monoclonal antibody NCL-CK13 was studied in specimens of craniopharyngioma, ameloblastoma and calcifying odontogenic cyst neoplasms and the mandible and maxillae of normal human fetuses. (who.int)
  • GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. (medscape.com)
  • In this paper the authors reveal state-of-the-art comprehension of the molecular biology of craniopharyngioma and the consequent therapeutic implications. (medscape.com)
  • Expression and growth dependency of the insulin-like growth factor I receptor in craniopharyngioma cells: a novel therapeutic approach. (medscape.com)
  • Operative outcomes and adjuvant treatment of purely third ventricle craniopharyngioma after a transcallosal approach. (medscape.com)
  • There may be long-term hormone, vision, and nervous system problems after craniopharyngioma is treated. (medlineplus.gov)
  • It can be used as a diagnostic aid in such conditions as panhypopituitarism, pituitary dwarfism, chromophobe adenoma, postsurgical craniopharyngioma, hypophysectomy, pituitary trauma, acromegaly, gigantism and problems of growth and stature. (nih.gov)